Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small-Cell-Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01588145
What this trial is testing

Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Hanmi Pharmaceutical Company Limited 273
Testing effectiveness (Phase 2)Looking for participantsNCT07103395
What this trial is testing

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
Sun Yat-sen University 56
Testing effectiveness (Phase 2)Study completedNCT00006019
What this trial is testing

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
LeukemiaLung CancerLymphoma+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Not applicableEnded earlyNCT02671045
What this trial is testing

Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small Cell Lung
Cota Inc. 649
Testing effectiveness (Phase 2)Active Not RecruitingNCT04868877
What this trial is testing

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Who this might be right for
Non-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more
Merus B.V. 194
Not applicableUnknownNCT01891123
What this trial is testing

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Who this might be right for
Non-small Cell Lung CancerBreast CancerNasal Cancer
Sun Yat-sen University 300
Not applicableStudy completedNCT01156623
What this trial is testing

Endobronchial Ultrasound Guided Transbronchial Aspiration (EBUS-TBNA) in Non Small Cell Lung Cancer (NSCLC) in a Tuberculosis-endemic Country

Who this might be right for
Non-small Cell Lung Cancer
Chang Gung Memorial Hospital 36
Large-scale testing (Phase 3)Looking for participantsNCT05654454
What this trial is testing

A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Mabscale, LLC 620
Not applicableUnknownNCT00192829
What this trial is testing

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Who this might be right for
Non-Small Cell Lung CarcinomaVenous Thromboembolism
Rambam Health Care Campus 100
Large-scale testing (Phase 3)Study completedNCT01282437
What this trial is testing

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Radical TreatmentStage III Non-Small Cell Lung Cancer
Maastricht Radiation Oncology 315
Testing effectiveness (Phase 2)Study completedNCT00103831
What this trial is testing

Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Bristol-Myers Squibb
Early research (Phase 1)UnknownNCT04142931
What this trial is testing

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV MelanomaTriple Negative Breast Cancer+1 more
Dr. Ronnie Shapira 30
Testing effectiveness (Phase 2)Study completedNCT03472053
What this trial is testing

BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Stage IIIB
BioMarck Pharmaceuticals, Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Looking for participantsNCT07330037
What this trial is testing

TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 41
Early research (Phase 1)Study completedNCT02145637
What this trial is testing

Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC
Yonsei University 30
Testing effectiveness (Phase 2)Study completedNCT00238875
What this trial is testing

A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403)

Who this might be right for
T1N0M0 Non-small Cell Lung Cancer
Haruhiko Fukuda 167
Testing effectiveness (Phase 2)Active Not RecruitingNCT02422381
What this trial is testing

MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Providence Health & Services 16
Testing effectiveness (Phase 2)UnknownNCT00809237
What this trial is testing

Hydroxychloroquine and Gefitinib to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
National University Hospital, Singapore 71
Next Page